Bladder Cancer

Official Journal of the Bladder Cancer Advocacy Network (BCAN)

Volume

7, 4 issues

Latest issue

7:3 online 31 August 2021

Next issue

7:4 scheduled for November 2021

Back volumes

From volume 1, 2015

ISSN print

2352-3727

ISSN online

2352-3735

Aims & Scope

Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.

Editorial Board

Editors-in-Chief

Seth P. Lerner, MD
Baylor College of Medicine
Scott Department of Urology, Houston, Texas
USA
Email: blc@iospress.com

Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center, Los Angeles, California
USA
Email: blc@iospress.com

Associate Editors for Reviews

Andrea B. Apolo, MD
National Cancer Institute, U.S. Department of Health and Human Services, Rockville
USA

Georgios Gakis, MD, PhD
University Hospital Würzburg, Department of Urology, Würzburg
Germany

Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria
Australia

Associate Editor of Challenging Cases in Urothelial Cancer

Mark S. Soloway, MD
Memorial Healthcare System, Aventura
USA

Associate Editors of Clinical Trials Corner

Piyush K. Agarwal, MD
University of Chicago Medicine, Chicago
USA

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Medical Oncology, Roma
Italy

Editor of Paper Alert

Edward M. Messing, MD
University of Rochester Medical Center, Department of Urology, Rochester
USA

Associate Editors

Joaquim Bellmunt, MD, PhD
Harvard Medical School, Beth Israel Deaconess Medical Center, Boston
USA

David J. DeGraff, PhD
Pennsylvania State University College of Medicine, Department of Pathology, Hershey
USA

Lars Dyrskjøt, PhD
Aarhus University, Department of Molecular Medicine, Aarhus
Denmark

Jason A. Efstathiou, MD, DPhil
Massachusetts General Hospital, Harvard Medical School, Radiation Oncology, Boston
USA

Thomas Flaig, MD
University of Colorado, Division of Medical Oncology, Aurora
USA

Donna Hansel, MD, PhD
Oregon Health & Science University, Department of Pathology & Laboratory Medicine, Portland
USA

Arndt Hartmann, MD
University Erlangen-Nürnberg, Institute of Pathology, Erlangen
Germany

Anne Kiltie, MA, DM, DSc
University of Oxford, Department of Oncology, Oxford
United Kingdom

Yair Lotan, MD
UT Southwestern Medical Center, Urology Clinic, Dallas
USA

S. Bruce Malkowicz, MD
Hospital of the University of Pennsylvania, Philadelphia
USA

Surena F. Matin, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston
USA

David McConkey, PhD
Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore
USA

Matt Milowsky, MD
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill
USA

Valeria Panebianco, MD
University of Rome La Sapienza, Department of Radiological Sciences, Oncology and Pathology, Rome
Italy

Francisco X. Real, MD, PhD
CNIO (Spanish National Cancer Research Centre), Molecular Oncology Programme, Madrid
Spain

Bas W.G. van Rhijn, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Surgical Oncology, Amsterdam
The Netherlands

Gottfrid Sjödahl, Ph.D.
Lund University, Department of Translational Medicine, Lund
Sweden

Angela B. Smith, MD, MS, FACS
UNC-Chapel Hill School of Medicine, Department of Urology, Chapel Hill
USA

George Thalmann, MD
University of Bern, Department of Urology, Bern
Switzerland

Xue-Ru Wu, MD
New York University (NYU), Department of Urology/Pathology, New York
USA

Diane Zipursky Quale, BA, JD
Bladder Cancer Advocacy Network (BCAN), Bethesda
USA

Alexandre R. Zlotta, MD, PhD
Sinai Health System, Uro-Oncology, Lunenfeld-Tanenbaum Research Institute, Toronto
Princess Margaret Cancer Centre, University Health Network, Department of Surgical Oncology, Urology, Toronto 
Canada

 

Social Media Associate Editor

Bishoy M. Faltas, MD
Weill Cornell Medicine, New York
USA

Assistant Social Media Editor

Kyrillus Shohdy, MD
Weill Cornell Medicine, New York
USA

Editorial Board

Cory Abate-Shen, PhD
Columbia University Medical Center, Department of Molecular Pharmacology and Therapeutics, New York
USA

Phillip Abbosh, MD, PhD
Fox Chase Cancer Center at Temple University Hospital, Molecular Therapeutics, Philadelphia
USA

Hikmat Al-Ahmadie, MD
Memorial Sloan-Kettering Cancer Center, Department of Pathology, New York
USA
    
Matthew L. Albert, MD, PhD
Institut Pasteur, Department of Immunology, Paris
France
    
Jessie Au, PharmD, PhD
Optimum Therapeutics, San Diego
USA

Marko Babjuk, MD
Motol University Hospital and 2nd Faculty of Medicine, Department of Urology, Prague, Czech Republic
USA

Rick Bangs, MBA, PMP, Patient Advocate, Pittsford
USA

Trinity Bivalacqua, MD, PhD
Johns Hopkins Medicine, Department of Urology, Surgery and Oncology, Baltimore
USA

Peter Black, MD
University of British Columbia, Department of Urology, Vancouver
Canada

Bernard Bochner, MD
Memorial Sloan-Kettering Cancer Center, Department of Urology, Surgery and Oncology, New York
USA

James Catto, MD, PhD
The University of Sheffield, Academic Urology Unit, Sheffield
United Kingdom
    
Karim Chamie, MD
University of California Los Angeles, Department of Urology, Los Angeles
USA

Keith Syson Chan, MD
Samuel Oschin Comprehensive Cancer Institute, Academic Pathology, Cedars-Sinai Medical Center, Los Angeles
USA

Sam S. Chang, MD
Vanderbilt University Medical Center, Department of Urology, Nashville
USA

Liang Cheng, MD
Indiana University, Department of Pathology & Laboratory Medicine, Indianapolis
USA

Richard J. Cote, MD
Washington University, Department of Pathology and Immunology, St Louis
USA

Bogdan Czerniak, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Pathology, Houston
USA

Garrett M. Dancik, PhD
Eastern Connecticut State University, Department of Computer Science, Willimantic
USA

Siamak Daneshmand, MD
University of Southern California, Department of Urology, Los Angeles
USA
    
Ian D. Davis, MBBS (Hons), PhD, FRACP, FAChPM
Monash University and Eastern Health, Eastern Health Clinical School, Box Hill
Australia

Colin P.N. Dinney, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Houston
USA

Matthew Galsky, MD
Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York
USA

Scott M. Gilbert, MD
H. Lee Moffitt Cancer Center & Research Institute, Department of Urology, Tampa
USA

Peter J. Goebell, MD, PhD
Universitätsklinikum Erlangen, Department of Urology, Erlangen
Germany

John Gore, MD
University of Washington, Department of Urology, Seattle
USA

Noah Hahn, MD
Johns Hopkins University School of Medicine, Department of Oncology and Urology, Baltimore
USA

Richard Hautmann, MD
Universität Ulm, Department of Urology, Ulm, Germany
USA

Jean Heather Hoffman-Censits, MD
Johns Hopkins University
USA

Jer-Tsong Hsieh, PhD
UT Southwestern Medical Center, Department of Urology, Dallas
USA

Molly A. Ingersoll, PhD
Institut Pasteur, Department of Immunology, Paris
France
    
Ashish M. Kamat, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston
USA

Lawrence Karsh, MD, FACS
The Urology Center of Colorado, Department of Clinical Research, Denver
USA

Wassim Kassouf, MD
McGill University Health Center, Department of Urology, Montreal
Canada
    
Lambertus (Bart) Kiemeney, PhD
Radboud University Medical Center, Department of Health Evidence, Nijmegen
The Netherlands

William Kim, MD
University of North Carolina, Department of Medicine, Chapel Hill
USA
    
Deborah W. Knapp, DVM
Purdue University, Department of Veterinary Clinical Sciences, West Lafayette
USA
    
Margaret Knowles, PhD
Leeds Institute of Cancer & Pathology, Department of Experimental Oncology, Leeds
United Kingdom
    
Badrinath Konety, MD
University of Minnesota, Department of Urology, Minneapolis
USA
    
David J. Kwiatkowski, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Department of Medicine, Boston
USA

Donald Lamm, MD
University of Arizona, Department of Surgery, Phoenix
USA

David Latini, PhD
Baylor College of Medicine, Department of Urology, Houston
USA

Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria
Australia

Cheryl Lee, MD
University of Michigan Hospitals, Cancer & Geriatrics Ctr, Ann Arbor
USA

Vinata Lokeshwar, PhD
Augusta University Medical College of Georgia, Department of Biochemistry and Molecular Biology, Augusta
USA
    
Nuria Malats, MD
CNIO (Spanish National Cancer Research Centre), Genetic and Molecular Epidemiology Group, Madrid
Spain

Kazumasa Matsumoto, MD
Kitasato University, Department of Urology, Kanagawa
Japan

James McKiernan, MD
Columbia University, Department of Urology, New York
USA

Reza Mehrazin, MD
The Mount Sinai Hospital, Department of Urology, New York
USA

Maxwell Meng, MD
University of California San Francisco, Department of Urology, San Francisco
USA

Timur Mitin, MD, PhD
Oregon Health and Science University, Portland
USA

Anirban P. Mitra, MD, PhD
University of Southern California, Institute of Urology, Los Angeles
USA

Ofer Nativ, MD
Bnai Zion Medical Center, Department of Urology, Haifa
Israel

Roman Nawroth, PhD
Klinikum rechts der Isar, Technical University of Munich, Department of Urology, Munich
Germany

Matthew Nielsen, MD, UNC School of Medicine, Department of Urology, Chapel Hill
USA

Hiroyuki Nishiyama, MD, PhD
University of Tsukuba, Department of Urology, Tsukuba
Japan

Michael A. O'Donnell, MD
University of Iowa Carver College of Medicine, Department of Urology, Iowa City
USA

Torben Ørntoft, MD 
Aarhus University Hospital, Department of Clinical Medicine, Aarhus
Denmark

Joan Palou Redorta, MD, PhD
Universitat Autònoma de Barcelona, Fundació Puigvert, Department of Urology, Barcelona
Spain

Howard L. Parnes, MD
National Cancer Institute, NIH, Devision of Cancer Prevention, Bethesda
USA
    
Dan Petrylak, MD
Yale University, Department of Medical Oncology, New Haven
USA

Elizabeth R. Plimack, MD
Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia
USA

Kamal Pohar, MD
Ohio State University, Department of Urology, Columbus
USA

Michael P. Porter, MD
University of Washington, Department of Urology, Seattle
USA

Ludmila Prokunina-Olsson, PhD
National Cancer Institute, Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, Bethesda
USA

Sarah P. Psutka
University of Washington, Seattle
USA

Nagireddy Putluri, Ph.D
Baylor College of Medicine, Dept. of Molecular and Cellular Biology, Houston
USA

David Quinn, MBBS, PhD
University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles
USA

François Radvanyi, PhD
Institut Curie - UMR 144 - CNRS, Department of Cell Biology and Cancer, Paris
France

Derek Raghavan, MD, PhD
Levine Cancer Institute, Atrium Health, Charlotte
USA

Leonardo O. Reis, MD, MSc, PhD
University of Campinas, Sao Paulo
Brazil

Cyrill Rentsch, MD, PhD
University Hospital Basel, Division of Urology, Basel
Switzerland

Jonathan Rosenberg, MD
Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, New York
USA

Arthur I. Sagalowsky, MD
UT Southwestern Medical Center, Department of Urology, Dallas
USA

Maria De Santis, MD
Charité University Hospital, Interdisciplinary GU Oncology, Department of Urology, Berlin
Germany

Marta Sánchez-Carbayo, PhD
University of the Basque Country, Department of Cancer Research, Bilbao
Spain
    
Bernd J. Schmitz-Dräger, MD, PhD
Friedrich-Alexander University, Department of Urology and Pediatric Urology, Erlangen
Germany

Mark P. Schoenberg, MD
The Albert Einstein College of Medicine & The Montefiore Medical Center, Department of Urology, New York
USA

John P. Sfakianos, MD
Urologic Oncology, Department of Urology, Icahn School of Medicine at Mount Sinai, New York
USA

Shahrokh F. Shariat, MD, PhD
Medical University Vienna, Department of Urology, Vienna
Austria

Padmanee Sharma, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology and Immunology, Houston
USA

Eila C. Skinner, MD
Stanford University, Department of Urology, Stanford, USA
USA

Carolyn L. Smith, PhD
Baylor College of Medicine, Molecular & Cellular Biology, Houston
USA

Norm Smith, MD
Northshore University HealthSystem, Chicago
USA

Steven Christopher Smith, MD, PhD
Virginia Commonwealth University, School of Medicine, Richmond, USA
USA

Walter Stadler, MD, FACP
University of Chicago, Comprehensive Cancer Center, Chicago, USA, , Gary Steinberg, MD, NYU Langone Health, Department of Urology, New York
USA

Gary Steinberg, MD
NYU Langone Health, Department of Urology, New York
USA

Arnulf Stenzl, MD
Universitätsklinikum Tübingen, Department of Urology, Tübingen
Germany

Seth Strope, MD
Baptist MD Anderson Cancer Center, Jacksonville, Florida
USA

Hyun Hwan Sung, MD, PhD
Samsung Medical Center, Department of Urology, Seoul
Korea

Robert Svatek, MD, MSCI
UT Health Science Center San Antonio, Department of Urology, San Antonio
USA

John A. Taylor, III, MD, MS
University of Kansas Medical Center, Department of Urology, Kansas City
USA

Jennifer M. Taylor, MD, MPH
Baylor College of Medicine/DeBakey VAMC, Houston
USA

Antonia Vlahou, PhD
Biomedical Research Foundation Academy of Athens, Department of Systems Biology, Athens
Greece

Nicholas Vogelzang, MD, FASCO
Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas
USA

J. Alfred Witjes, MD, PhD
Radboud University Nijmegen, Department of Urology, Nijmegen
The Netherlands

Statistical and Bioinformatics Editorial Board

Debashis Ghosh, PhD
University of Colorado, Department of Biostatistics and Informatics, Aurora
USA

Susan Groshen, PhD, University of Southern California, Department of Preventive Medicine, Los Angeles
USA

Michael C. Sachs, PhD
Karolinska Institute, Department of Medical Epidemiology and Biostatistics, Stockholm
Sweden

Richard Sylvester, ScD
EORTC, Brussels
Belgium

Jeremy Taylor, PhD
University of Michigan, Department of Biostatistics, Ann Arbor
USA

Author Guidelines

By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

See instructions to authors

Abstracted/Indexed in

Embase
Google Scholar
Scopus
Web of Science: Current Contents®/Life Sciences
Web of Science: Emerging Sources Citation Index
Web of Science: Science Citation Index-Expanded (SciSearch®)

Extra

New Associate Editor for Reviews: As of March 2021, we are pleased to announce that Editorial Board member Andrea Apolo has been promoted to become Associate Editor for Reviews, alongside Georgios Gakis and Nathan Lawrentschuk. The previous editor Matt Galsky steps down and the Editors-in-Chief thank him for his many contributions to the journal.

Science Citation Index-Expanded: As of Sep 2019, Bladder Cancer is covered in the Science Citation Index-Expanded category in the Web of Science, which will provide greater discoverability for BLC articles leading to measurable citations and the journal’s first impact factor. 

Newsletter: Be sure to sign up to the BLC newsletter to receive alerts of new issues and other journal news. Sign up via this link tiny.cc/BLCsignup & you can read the latest newsletter here

Bladder Cancer on Twitter: You can follow us on Twitter at @BladderCaJrnl – Bishoy Faltas runs the account as our social media editor, sharing our journal content and news of interest to the bladder cancer research community. The assistant social media editor is Kyrillus Shohdy.  

Emerging Sources Citation Index: As of Mar 2018, Bladder Cancer is covered in the Emerging Sources Citation Index in the Web of Science.

BCAN Partnership: In Jan 2018, a new partnership was announced between the Bladder Cancer Advocacy Network (bcan.org) and our journal Bladder Cancer – which, as of Vol.4, Iss.1, is the official journal of BCAN. Read more at: tiny.cc/BLC_PR.
 

BLC is the official journal of BCAN